Diagnostic News and Research

RSS

CareChex releases new study on University Hospital Care in the U.S.

CareChex, a division of The Delta Group specializing in rating the quality of hospital and physician care, today released a new study, An Assessment of the Quality of University Hospital Care in the U.S., that investigates whether or not university hospitals outperform other hospitals on objective measures of quality.

2 Nov 2010

New REACT medical trial for early diagnosis of lung cancer

Physicians at El Camino Hospital are starting a medical trial called REACT that they hope may give doctors a new and cost-effective tool for early diagnosis of lung cancer, the deadliest of the common cancers.

2 Nov 2010

GSN closes $12M Series C financing

Gene Security Network, Inc. today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners.

2 Nov 2010

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.

2 Nov 2010

Micronics receives $244,479 cash grant under QTDP program

Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.

2 Nov 2010

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

Rubicon Genomics today reported data demonstrating that its PicoPlex kits currently marketed for the analysis of single cells for research and diagnostic applications also provide important advantages for genetic and epigenetic profiling using next-generation sequencing (NGS).

2 Nov 2010

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition.

2 Nov 2010

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.

1 Nov 2010

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

1 Nov 2010

Life Technologies announces launch of new sequencer to deliver genomic data

Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.

1 Nov 2010

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Oncimmune® LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, today announced that two oral presentations and five poster presentations during this week's American College of Chest Physicians' (ACCP) annual meeting in Vancouver will collectively highlight the clinical and economic benefits of EarlyCDT-Lung.

1 Nov 2010

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

Researchers are calling for clear guidelines on childhood stroke after a study, published in the November issue of Acta Paediatrica, found wide variations in time lag to diagnosis, investigation and treatment.

1 Nov 2010

New PHQ-9 screening test evaluates major depression in adults

Primary-care clinicians know teen depression is common, but they've lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children's, and Group Health report the PHQ-9 is a good screening test for major depression in adolescents.

1 Nov 2010

Dance for the Cure of Prostate Cancer: A national awareness and fundraising campaign

Today, AdMeTech Foundation in cooperation with Nick Kosovich of Dancing with the Stars, Arthur Murray International (AMI), Philips Healthcare, Mary Murphy of Fox TV Hit So You Think You Can Dance and other key leaders of the dancing community have launched Dance for the Cure of Prostate Cancer as a national awareness and fundraising campaign to end the prostate cancer crisis.

30 Oct 2010

HDL and Virginia governor announce $4.2 million investment for expanding operations

Health Diagnostic Laboratory (HDL, Inc.) and Governor Bob McDonnell have announced an investment of $4.2 million in HDL, Inc. operations, resulting in the creation of 213 new jobs in the City of Richmond. HDL, Inc., located in the Virginia BioTechnology Research Park, will expand its clinical laboratory, diagnostics and clinical trial services, as well as its physician/patient consulting.

30 Oct 2010

Roche announces U.S. introduction of cobas e 602 analyzer

Roche announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new immunoassay module with two existing clinical chemistry modules to create an integrated platform with 24 unique system configurations to match their specific testing needs.

From Roche Sequencing and Life Science 30 Oct 2010

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.

29 Oct 2010

Research on brain circuit activity may pave way to find biomarker for PTSD

University of Minnesota Medical School and Minneapolis Veterans Affair Medical Center researchers have discovered a correlation between increased circuit activity in the right side of the brain and the debilitating, involuntary flashbacks triggered by post traumatic stress disorder (PTSD).

29 Oct 2010

Mechanism that controls embryonic development could also prevent cancer

Researchers from Mount Sinai School of Medicine have identified a mechanism controlling the function of a protein that binds to DNA during embryonic development and may function to prevent abnormal tumor growth.

29 Oct 2010

ZyGEM announces advancement in microfluidics platform for DNA testing

ZyGEM Corp. Ltd., today announced several developments supporting the advancement of its integrated microfluidics platform designed to dramatically decrease the time, complexity and cost of conducting DNA testing. These include presentations at two key scientific meetings, as well as the issuance of a new patent relating to separation technology that supports and further strengthens ZyGEM's intellectual property portfolio.

29 Oct 2010

Diagnostic News and Research

CareChex releases new study on University Hospital Care in the U.S.

New REACT medical trial for early diagnosis of lung cancer

GSN closes $12M Series C financing

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

Micronics receives $244,479 cash grant under QTDP program

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

National Jewish Health's chronic urticaria diagnostic assay receives US patent

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

Life Technologies announces launch of new sequencer to deliver genomic data

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

New PHQ-9 screening test evaluates major depression in adults

Dance for the Cure of Prostate Cancer: A national awareness and fundraising campaign

HDL and Virginia governor announce $4.2 million investment for expanding operations

Roche announces U.S. introduction of cobas e 602 analyzer

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

Research on brain circuit activity may pave way to find biomarker for PTSD

Mechanism that controls embryonic development could also prevent cancer

ZyGEM announces advancement in microfluidics platform for DNA testing

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News